Models:
Joseph Gordon
joseph-gordon/
ClinicalTrialsElig
0
Downloads: 1
[c09aa8]: / clusters / final9knumclusters / clust_947.txt

Download this file

103 lines (102 with data), 6.4 kB 

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
Within 14 days of treatment initiation: Hemoglobin >= 9 g/dL OR >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Within 21 days of treatment initiation:\r\nHemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 8 g/dL (5.0 mmol/L)

Hemoglobin >= 9 g/dL (5.6 mmol/L)

Hemoglobin ? 8.0 g/dL (4.96 mmol/L)

SAFETY RUN-IN: Within 10 days of registration: Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

RANDOMIZED PHASE II CLINICAL TRIAL: Within 10 days of registration: Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin ? 9 g/dL or ? 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L.

Hemoglobin >= 9.0 g/dL (5.58 mmol/L)

Hemoglobin >= 8.5 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9.0 g/dL (1.4 mmol/L)

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

At time of registration and within 4 weeks prior to initiating on-protocol treatment: Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Within 10 days prior to the start of study treatment: Hemoglobin >= 9.0 g/dL or >= 5.6 mmol/L

Hemoglobin >= 8 g/dL or >= 5.0 mmol/L within 21 days of treatment initiation

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L, performed within 28 days of treatment initiation

Hemoglobin 8.0 g/dL (5.0 mmol/L)

Within 7 days of registration: Hemoglobin >= 9.0 g/gL or >= 5.6 mmol/L, without recent transfusion

Hemoglobin ?9.0 g/dL (?5.6 mmol/L);.

Hemoglobin >= 7 g/dL or >= 5.6 mmol/L within 14 days prior to registration

Hemoglobin >= 9 g/dL (5.58 mmol/L)

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Performed 28 days prior to study registration up to the first dose of study drug: hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Performed within 14 days (+3 working days) of treatment initiation: Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Performed within 14 days of treatment initiation: Hemoglobin >= 8 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9.0 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L except in cases of marrow infiltration by lymphoma

Hemoglobin >= 9 g/dL (5.58 mmol/L)

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin < 9 g/dL (5.6 mmol/L)

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9.0 g/dL (1.4 mmol/L)

Performed within 28 days prior to study registration up to the first dose of study drug: Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L, performed within 10 days of treatment initiation

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Performed within 10 days of treatment initiation; hemoglobin ? 9 g/dL or ? 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Magnesium < 1.4 mg/dl (< 0.4 mmol/L) or > 3 mg/dl (> 1.23 mmol/L) despite intervention to normalize levels

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL (5.6 mmol/L); subjects may not have had a transfusion within 7 days of screening assessment

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin ? 9 g/dL or ? 5.6 mmol/L within 7 days of treatment initiation

Hemoglobin ? 9g/dL or ? 5.6 mmol/L

Hemoglobin >= 8 g/dL or >= 4.96 mmol/L

Magnesium < 0.9 mg/dl (< 0.4 mmol/L) or > 3 mg/dl (> 1.23 mmol/L) despite intervention to normalize levels

Magnesium < 0.9 mg/dl (< 0.4 mmol/L) or > 3 mg/dl (> 1.23 mmol/L) despite intervention to normalize levels

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL OR >= 5.6 mmol/L

Within 30 days prior to treatment initiation: Hemoglobin >= 9 g/dL or >= 5.6 mmol/L; transfusions permitted

Hemoglobin >= 9.0 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL (5.58 mmol/L)

Hemoglobin greater than 8.0 g/dL (= 80 g/L or 4.9 mmol/L)

Hemoglobin ?9 g/dL or ?5.6 mmol/L

Hemoglobin >=9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin ?9 g/dL or ?5.6 mmol/L- without qualifications

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin ? 8.0 g/dL (4.96 mmol/L)

Hemoglobin < 8.5 g/dL (< 5.3 mmol/L)

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L, performed within 14 days prior to registration

Within 14 days of treatment initiation: Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Performed within 28 days of radiation therapy: Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L, performed within 28 days of treatment initiation

Hemoglobin >= 9 g/dL (or >= 5.6 mmol/L)

Hemoglobin >= 9 g/dL OR >= 5.6 mmol/L (labs should be performed within 14 days of treatment initiation)

Hemoglobin >= 9 g/dL (5.6 mmol/L) (tested within 14 days prior to registration)\r\n* Subjects may not have had a transfusion within 7 days of screening assessment

Hemoglobin >= 9 g/dL (5.6 mmol/L); subjects may not have had a transfusion within 7 days of screening assessment

Hemoglobin >= 9 g/dL (5.6 mmol/L); subjects may not have had a transfusion within 7 days of screening assessment

Hemoglobin >= 9 g/dL (5.6 mmol/L); subjects may not have had a transfusion within 7 days of screening assessment

Hemoglobin >= 9 g/dL (5.6 mmol/L); subjects may not have had a transfusion within 7 days of screening assessment

Hemoglobin >= 9 g/dL (5.6 mmol/L)

Hemoglobin ?8.0 g/dL (?4.96 mmol/L)

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin ? 9 g/L (?5.6 mmol/L).

Hemoglobin ? 8.0 g/dL (4.96 mmol/L)

Performed within 10 days of treatment initiation: Hemoglobin >= 9 g/dL OR >= 5.6 mmol/L

Bone Marrow: Absolute neutrophil count ANC ? 1,500/mm3 (1.5 × 109/L); Platelets ? 100,000/mm3 (100 × 109/L); Hemoglobin ? 9.5 g/dL (1.4 mmol/L). Subjects with hemoglobin ? 9.5 g/dL (1.4 mmol/L) following transfusion are eligible;

Hemoglobin ? 9 g/dL or ? 5.6 mmol/L

Hemoglobin >= 10 g/dL (6.2 mmol/L)

Hemoglobin < 9 g/dL (5.6 mmol/L)

Performed within 10 days of treatment initiation: Hemoglobin >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL or >= 5.6 mmol/L, performed within 10 days of treatment initiation

Hemoglobin >= 9.0 g/dL or >= 5.6 mmol/L

Hemoglobin >= 9 g/dL (5.6 mmol/L) (evaluated within 28 days of randomization); subjects may not have had a transfusion within 7 days of screening assessment

Hemoglobin >= 8.5 g/dL or >= 5.6 mmol/L, performed within 10 days of treatment initiation

Hemoglobin > 5.6 mmol/L (9 g/dL) at the screening visit

Hemoglobin >= 8.5 g/dL or >= 5.6 mmol/L